Consensus statement on the definition of neurogenic supine hypertension in cardiovascular autonomic failure by the American Autonomic Society (AAS) and the European Federation of Autonomic Societies (EFAS): Endorsed by the European Academy of Neurology (EAN) and the European Society of Hypertension (ESH)

Clinical Autonomic Research

Volumn 28, Issue 4, 2018, Pages 355-362

  Fanciulli, Alessandra ^a   Jordan, Jens ^b   Biaggioni, Italo ^c   Calandra–Buonaura, Giovanna ^d,e   Cheshire, William P ^f   Cortelli, Pietro ^d,e   Eschlboeck, Sabine ^a   Grassi, Guido ^g,h   Hilz, Max J ^i,j   Kaufmann, Horacio ^k   Lahrmann, Heinz ^l   Mancia, Giuseppe ^m   Mayer, Gert ^a   Norcliffe–Kaufmann, Lucy ^k   Pavy–Le Traon, Anne ^n,o   Raj, Satish R ^p   Robertson, David ^c   Rocha, Isabel ^q   Struhal, Walter ^r   Thijs, Roland ^s,t   Tsioufis, Konstantinos P ^u   van Dijk, J Gert ^t   Wenning, Gregor K ^a   more..

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b UNIVERSITY OF COLOGNE   (Germany)

^c VANDERBILT UNIVERSITY   (United States)

^d UNIVERSITY OF BOLOGNA   (Italy)

^e IRCCS   (Italy)

^f MAYO CLINIC   (United States)

^g UNIVERSITY OF MILANO BICOCCA   (Italy)

^h IRCCS MULTIMEDICA   (Italy)

ⁱ UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^j MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^k NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^l Physician in Private Practice   (Austria)

^m Centro di Fisiologia Clinica e Ipertensione   (Italy)

ⁿ TOULOUSE UNIVERSITY HOSPITAL   (France)

^o CNRS   (France)

^p UNIVERSITY OF CALGARY   (Canada)

^q INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

^r Universitätsklinikum Tulln Karl Landsteiner Privatuniversität für Gesundheitswissenschaften   (Austria)

^s STICHTING EPILEPSIE INSTELLINGEN NEDERLAND SEIN   (Netherlands)

^t LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^u UNIVERSITY OF ATHENS   (Greece)

more..

Author keywords

ABPM; Autonomic failure; Neurogenic orthostatic hypotension; Neurogenic supine hypertension; Nocturnal hypertension

Indexed keywords

AUTONOMIC DYSFUNCTION; BLOOD PRESSURE MONITORING; CLINICAL FEATURE; CONSENSUS; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; EPIDEMIOLOGICAL DATA; HUMAN; HYPERTENSION; MEDLINE; NEUROGENIC SUPINE HYPERTENSION; NIGHT SLEEP; ORTHOSTATIC HYPOTENSION; PATHOPHYSIOLOGY; PATIENT CARE; PREVALENCE; PROGNOSIS; REVIEW; SCREENING; SUPINE POSITION; SYSTOLIC BLOOD PRESSURE; AUTONOMIC NEUROPATHY; CARDIOVASCULAR DISEASE; COMPLICATION; EUROPE; PHYSIOLOGY; PRACTICE GUIDELINE; UNITED STATES;

AUTONOMIC NERVOUS SYSTEM DISEASES; CARDIOVASCULAR DISEASES; CONSENSUS; EUROPE; HUMANS; HYPERTENSION; SUPINE POSITION; UNITED STATES;

EID: 85046891738     PISSN: 09599851     EISSN: 16191560     Source Type: Journal    
DOI: 10.1007/s10286-018-0529-8     Document Type: Review

References (63)

1. Benarroch EE (2014) The clinical approach to autonomic failure in neurological disorders. Nat Rev Neurol 10(7):396–407
2. Freeman R, Wieling W, Axelrod FB et al (2011) Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome. Clin Auton Res 21(2):69–72
3. Fanciulli A, Gobel G, Ndayisaba JP et al (2016) Supine hypertension in Parkinson’s disease and multiple system atrophy. Clin Auton Res 26(2):97–105
4. Cicolini G, Pizzi C, Palma E et al (2011) Differences in blood pressure by body position (supine, Fowler’s, and sitting) in hypertensive subjects. Am J Hypertens 24(10):1073–1079
5. Krzesinski P, Stanczyk A, Gielerak G, Piotrowicz K, Banak M, Wojcik A (2016) The diagnostic value of supine blood pressure in hypertension. Arch Med Sci 12(2):310–318
6. Goldstein DS, Pechnik S, Holmes C, Eldadah B, Sharabi Y (2003) Association between supine hypertension and orthostatic hypotension in autonomic failure. Hypertension 42(2):136–142
7. Parati G, Stergiou G, O’Brien E et al (2014) European Society of Hypertension practice guidelines for ambulatory blood pressure monitoring. J Hypertens 32(7):1359–1366
8. Mancia G, Fagard R, Narkiewicz K et al (2013) 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 34(28):2159–2219
9. Wilcox CS, Aminoff MJ, Penn W (1974) Basis of nocturnal polyuria in patients with autonomic failure. J Neurol Neurosurg Psychiatry 37(6):677–684
10. Jordan J, Shannon JR, Pohar B et al (1999) Contrasting effects of vasodilators on blood pressure and sodium balance in the hypertension of autonomic failure. J Am Soc Nephrol 10(1):35–42
11. Pinna G, Pascale C, Fornengo P et al (2014) Hospital admissions for hypertensive crisis in the emergency departments: a large multicenter Italian study. PLoS One 9(4):e93542
12. Sandroni P, Benarroch EE, Wijdicks EF (2001) Caudate hemorrhage as a possible complication of midodrine-induced supine hypertension. Mayo Clin Proc 76(12):1275
13. Chaimberg KH, Travis KW (2002) Supine hypertension during general anesthesia in a patient taking midodrine. Anesth Analg 95(5):1196–1197 (table of contents)
14. Cilia R, Cereda E, Klersy C et al (2015) Parkinson’s disease beyond 20 years. J Neurol Neurosurg Psychiatry 86(8):849–855
15. Stubendorff K, Aarsland D, Minthon L, Londos E (2012) The impact of autonomic dysfunction on survival in patients with dementia with lewy bodies and Parkinson’s disease with dementia. PLoS One 7(10):e45451
16. CCalandra-Buonaura G, Guaraldi P, Sambati L, et al (2013) Multiple system atrophy with prolonged survival: is late onset of dysautonomia the clue? Neurol Sci 34(10):1875–1878
17. Petrovic IN, Ling H, Asi Y et al (2012) Multiple system atrophy-parkinsonism with slow progression and prolonged survival: a diagnostic catch. Mov Disord 27(9):1186–1190
18. O’Sullivan SS, Massey LA, Williams DR et al (2008) Clinical outcomes of progressive supranuclear palsy and multiple system atrophy. Brain 131(Pt 5):1362–1372
19. Tada M, Onodera O, Ozawa T et al (2007) Early development of autonomic dysfunction may predict poor prognosis in patients with multiple system atrophy. Arch Neurol 64(2):256–260
20. Watanabe H, Saito Y, Terao S et al (2002) Progression and prognosis in multiple system atrophy: an analysis of 230 Japanese patients. Brain 125(Pt 5):1070–1083
21. Maule S, Milan A, Grosso T, Veglio F (2006) Left ventricular hypertrophy in patients with autonomic failure. Am J Hypertens 19(10):1049–1054
22. Maule S, Milazzo V, Maule MM, Di Stefano C, Milan A, Veglio F (2012) Mortality and prognosis in patients with neurogenic orthostatic hypotension. Funct Neurol 27(2):101–106
23. Vagaonescu TD, Saadia D, Tuhrim S, Phillips RA, Kaufmann H (2000) Hypertensive cardiovascular damage in patients with primary autonomic failure. Lancet 355(9205):725–726
24. Garland EM, Gamboa A, Okamoto L et al (2009) Renal impairment of pure autonomic failure. Hypertension 54(5):1057–1061
25. Oh YS, Kim JS, Lee KS (2013) Orthostatic and supine blood pressures are associated with white matter hyperintensities in Parkinson disease. J Mov Disord 6(2):23–27
26. Pilleri M, Facchini S, Gasparoli E et al (2013) Cognitive and MRI correlates of orthostatic hypotension in Parkinson’s disease. J Neurol 260(1):253–259
27. Kim JS, Oh YS, Lee KS, Kim YI, Yang DW, Goldstein DS (2012) Association of cognitive dysfunction with neurocirculatory abnormalities in early Parkinson disease. Neurology 79(13):1323–1331
28. Gorell JM, Johnson CC, Rybicki BA (1994) Parkinson’s disease and its comorbid disorders: an analysis of Michigan mortality data, 1970 to 1990. Neurology 44(10):1865–1868
29. Tha KK, Terae S, Yabe I et al (2010) Microstructural white matter abnormalities of multiple system atrophy: in vivo topographic illustration by using diffusion-tensor MR imaging. Radiology 255(2):563–569
30. Lim TS, Lee PH, Kim HS, Yong SW (2009) White matter hyperintensities in patients with multiple system atrophy. J Neurol 256(10):1663–1670
31. Jones JD, Jacobson C, Murphy M, Price C, Okun MS, Bowers D (2014) Influence of hypertension on neurocognitive domains in nondemented Parkinson’s disease patients. Parkinsons Dis 2014:507529
32. Hohler AD, Zuzuarregui JR, Katz DI et al (2012) Differences in motor and cognitive function in patients with Parkinson’s disease with and without orthostatic hypotension. Int J Neurosci 122(5):233–236
33. Allcock LM, Kenny RA, Mosimann UP et al (2006) Orthostatic hypotension in Parkinson’s disease: association with cognitive decline? Int J Geriatr Psychiatry 21(8):778–783
34. Peralta C, Stampfer-Kountchev M, Karner E et al (2007) Orthostatic hypotension and attention in Parkinson’s disease with and without dementia. J Neural Transm 114(5):585–588
35. Brown RG, Lacomblez L, Landwehrmeyer BG et al (2010) Cognitive impairment in patients with multiple system atrophy and progressive supranuclear palsy. Brain 133(Pt 8):2382–2393
36. Deguchi K, Takeuchi H, Sasaki I, Tsukaguchi M, Touge T, Nishioka M (2001) Impaired novelty P3 potentials in multiple system atrophy—correlation with orthostatic hypotension. J Neurol Sci 190(1–2):61–67
37. Milazzo V, Di Stefano C, Milan A et al (2015) Cardiovascular complications in patients with autonomic failure. Clin Auton Res 25(3):133–140
38. Rothwell PM (2010) Limitations of the usual blood-pressure hypothesis and importance of variability, instability, and episodic hypertension. Lancet 375(9718):938–948
39. Umehara T, Matsuno H, Toyoda C, Oka H (2016) Clinical characteristics of supine hypertension in de novo Parkinson disease. Clin Auton Res 26(1):15–21
40. Shannon J, Jordan J, Costa F, Robertson RM, Biaggioni I (1997) The hypertension of autonomic failure and its treatment. Hypertension 30(5):1062–1067
41. Biaggioni I, Robertson RM (2002) Hypertension in orthostatic hypotension and autonomic dysfunction. Cardiol Clin 20(2):291–301 (vii)
42. Pavy-Le Traon A, Piedvache A, Perez-Lloret S et al (2016) New insights into orthostatic hypotension in multiple system atrophy: a European multicentre cohort study. J Neurol Neurosurg Psychiatry 87(5):554–561
43. Berganzo K, Diez-Arrola B, Tijero B et al (2013) Nocturnal hypertension and dysautonomia in patients with Parkinson’s disease: are they related? J Neurol 260(7):1752–1756
44. Fanciulli A, Strano S, Ndayisaba JP et al (2014) Detecting nocturnal hypertension in Parkinson’s disease and multiple system atrophy: proposal of a decision-support algorithm. J Neurol 261(7):1291–1299
45. Plaschke M, Trenkwalder P, Dahlheim H, Lechner C, Trenkwalder C (1998) Twenty-four-hour blood pressure profile and blood pressure responses to head-up tilt tests in Parkinson’s disease and multiple system atrophy. J Hypertens 16(10):1433–1441
46. Schmidt C, Berg D, Prieur S et al (2009) Loss of nocturnal blood pressure fall in various extrapyramidal syndromes. Mov Disord 24(14):2136–2142
47. Celedonio JE, Arnold AC, Dupont WD et al (2015) Residual sympathetic tone is associated with reduced insulin sensitivity in patients with autonomic failure. Clin Auton Res 25(5):309–315
48. Struhal W, Lahrmann H, Mathias CJ (2013) Incidence of cerebrovascular lesions in pure autonomic failure. Auton Neurosci 179(1–2):159–162
49. Madacsy L, Yasar A, Tulassay T et al (1995) Association of relative nocturnal hypertension and autonomic neuropathy in insulin-dependent diabetic children. Acta Biomed Ateneo Parmense 66(3–4):111–118
50. Chang J, Hou YP, Wu JL et al (2017) Blood pressure circadian rhythms and adverse outcomes in type 2 diabetics diagnosed with orthostatic hypotension. J Diabetes Investig 9(2):383–388
51. Arnold AC, Okamoto LE, Gamboa A et al (2016) Mineralocorticoid receptor activation contributes to the supine hypertension of autonomic failure. Hypertension 67(2):424–429
52. Arnold AC, Okamoto LE, Gamboa A et al (2013) Angiotensin II, independent of plasma renin activity, contributes to the hypertension of autonomic failure. Hypertension 61(3):701–706
53. Shannon JR, Jordan J, Diedrich A et al (2000) Sympathetically mediated hypertension in autonomic failure. Circulation 101(23):2710–2715
54. Arnold AC, Biaggioni I (2012) Management approaches to hypertension in autonomic failure. Curr Opin Nephrol Hypertens 21(5):481–485
55. Gamboa A, Shibao C, Diedrich A et al (2008) Excessive nitric oxide function and blood pressure regulation in patients with autonomic failure. Hypertension 51(6):1531–1536
56. Pavelic A, Krbot Skoric M, Crnosija L, Habek M (2017) Postprandial hypotension in neurological disorders: systematic review and meta-analysis. Clin Auton Res 27(4):263–271
57. Norcliffe–Kaufmann L, Kaufmann H (2014) Is ambulatory blood pressure monitoring useful in patients with chronic autonomic failure? Clin Auton Res 24(4):189–192
58. van Lieshout JJ, ten Harkel AD, Wieling W (2000) Fludrocortisone and sleeping in the head-up position limit the postural decrease in cardiac output in autonomic failure. Clin Auton Res 10(1):35–42
59. Gama RL, Tavora DG, Bomfim RC, Silva CE, de Bruin VM, de Bruin PF (2010) Sleep disturbances and brain MRI morphometry in Parkinson’s disease, multiple system atrophy and progressive supranuclear palsy—a comparative study. Parkinsonism Relat Disord 16(4):275–279
60. Ghorayeb I, Yekhlef F, Chrysostome V, Balestre E, Bioulac B, Tison F (2002) Sleep disorders and their determinants in multiple system atrophy. J Neurol Neurosurg Psychiatry 72(6):798–800
61. Calandra-Buonaura G, Provini F, Guaraldi P, Plazzi G, Cortelli P (2016) Cardiovascular autonomic dysfunctions and sleep disorders. Sleep Med Rev 26:43–56
62. Cuspidi C, Meani S, Valerio C et al (2007) Reproducibility of dipping/nondipping pattern in untreated essential hypertensive patients: impact of sex and age. Blood Press Monit 12(2):101–106
63. Stenehjem AE, Os I (2004) Reproducibility of blood pressure variability, white-coat effect and dipping pattern in untreated, uncomplicated and newly diagnosed essential hypertension. Blood Press 13(4):214–224